Prosonix is an innovative speciality pharmaceutical company developing a portfolio of inhaled respiratory medicines by design
Sep 11, 2014
Prosonix Confirms the Potential of its Multi-Component Particle™ Technology for Developing Novel...
Sep 2, 2014
Prosonix’ Marketing Authorisation Application for PSX1001 – a Generic Version of...
May 15, 2014
Prosonix to Present Results of Phase 2 Study of PSX1002 in COPD at ATS Meeting
19-20 Nov 2014
10-12 Dec 2014
Edinburgh, Scotland, UK